Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXX5RT
|
||||
| Drug Name |
(S)-1-(1H-indol-4-yloxy)-3-(4-(benzo[b]thiophen-2-yl)piperidin-1-yl)propan-2-ol
|
||||
| Synonyms |
CHEMBL300115
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C24H26N2O2S
|
||||
| Canonical SMILES |
O[C@H](COc1cccc2[nH]ccc12)CN3CCC(CC3)c4cc5ccccc5s4
|
||||
| InChI |
InChI=1S/C24H26N2O2S/c27-19(16-28-22-6-3-5-21-20(22)8-11-25-21)15-26-12-9-17(10-13-26)24-14-18-4-1-2-7-23(18)29-24/h1-8,11,14,17,19,25,27H,9-10,12-13,15-16H2/t19-/m0/s1
|
||||
| InChIKey |
YVOIIEQOIZEGMN-IBGZPJMESA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1A receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.